Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT06557304 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

NCT06557304 · ClinicalTrials.gov record · last posted 2024-08-21

The Real World Study of BTK Inhibitor in the Treatment of Chronic Lymphocytic Leukemia in China

Name: The Real World Study of BTK Inhibitor in the Treatment of Chronic Lymphocytic Leukemia in China — clinical trial record (NCT06557304)
Creator: DataLookout
License: https://creativecommons.org/licenses/by/4.0/

StatusNot Yet Recruiting

PhaseNot specified

SponsorPeking University People's Hospital

Started2024-09-01

View on ClinicalTrials.gov ↗

from the ClinicalTrials.gov record

This is a Multicenter, Retrospective Real-world Study of Zanubrutinib in the Treatment of Chronic Lymphocytic Leukemia in China

Amendment record 1 amendment on the ClinicalTrials.gov record

This ClinicalTrials.gov record has been amended once since 2024-08-13. DataLookout shows field-level changes from the day a trial enters its daily monitoring; earlier amendments are counted here from the ClinicalTrials.gov version history. See every version on ClinicalTrials.gov ↗

Trial Details

NCT Number	NCT06557304
Lead Sponsor	Peking University People's Hospital
Conditions	CLL
Enrollment	1,000 participants
Start Date	2024-09-01
Primary Completion	2026-09-01 (estimated)
Study Completion	2027-12-30 (estimated)
Updated on ClinicalTrials.gov	2024-08-21